Financing our
Basic Research

Zoe Life Technologies AG’s basic research is financed by an ongoing licensing program, which allows licensees to use the basic technology for an appropriate fee.

In this context, Zoe Life Technologies AG also relies on retroactive royalty income, which is generally possible in Germany for up to ten years. The licensing program also extends to the territory of the United Kingdom of England. In addition to patent rights, Zoe Life Technologies AG includes an accompanying trademark portfolio. With the license contributions, the participants make an important contribution to research in the relevant technologies.

In addition to patent rights, Zoe Life Technologies AG includes an accompanying trademark portfolio. With the license contributions, the participants make an important contribution to research in the relevant technologies. Zoe Life Technologies AG sees itself as a research company and benefits from a broad understanding of licensees, which makes it possible to avoid legal action if possible. Preference is given to market participants who are cooperative in the licensing process. However, in order not to disadvantage these market participants, Zoe Life Technologies AG also actively enforces its property rights. However, a balanced licensing program is made possible, from which all participants profit.

Why license?

Right to use our basic technologies for a fee
01
Our technologies are patented and therefore protected against misuse
02
Misuse of our patents results in litigation executed by our lawyers
03

Interested in
Licensing our technologies?

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.